Gene · 64006
Papers4,423
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,021 to 1,040 of 4,423
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| GC-MS profiling of Bauhinia variegata major phytoconstituents with computational identification of potential lead inhibitors of SARS-CoV-2 Mpro. | Comput Biol Med | 2022 | 35667152 | PubTator, text mining | PubMed |
| RT-qPCR and ATOPlex sequencing for the sensitive detection of SARS-CoV-2 RNA for wastewater surveillance. | Water Res | 2022 | 35665675 | PubTator, text mining | PubMed |
| Prospective Medicinal Plants and Their Phytochemicals Shielding Autoimmune and Cancer Patients Against the SARS-CoV-2 Pandemic: A Special Focus on Matcha. | Front Oncol | 2022 | 35664773 | PubTator, text mining | PubMed |
| The interplay between lncRNAs, RNA-binding proteins and viral genome during SARS-CoV-2 infection reveals strong connections with regulatory events involved in RNA metabolism and immune response. | Theranostics | 2022 | 35664076 | PubTator, text mining | PubMed |
| SARS-CoV-2 Within-Host and in vitro Genomic Variability and Sub-Genomic RNA Levels Indicate Differences in Viral Expression Between Clinical Cohorts and in vitro Culture. | Front Microbiol | 2022 | 35663867 | PubTator, text mining | PubMed |
| Evolutionary dynamics of the severe acute respiratory syndrome coronavirus 2 genomes. | Med Rev (2021) | 2022 | 35658106 | PubTator, text mining | PubMed |
| Evolutionary Traits and Genomic Surveillance of SARS-CoV-2 in South America. | Glob Health Epidemiol Genom | 2022 | 35655960 | PubTator, text mining | PubMed |
| Therapy Targets SARS-CoV-2 Infection-Induced Cell Death. | Front Immunol | 2022 | 35655782 | PubTator, text mining | PubMed |
| Molecular pathogenesis of Japanese encephalitis and possible therapeutic strategies. | Arch Virol | 2022 | 35654913 | PubTator, text mining | PubMed |
| SARS-CoV-2 Omicron variant escapes neutralizing antibodies and T cell responses more efficiently than other variants in mild COVID-19 convalescents. | Cell Rep Med | 2022 | 35654046 | PubTator, text mining | PubMed |
| Luminescent Assay for the Screening of SARS-CoV-2 MPro Inhibitors. | Chembiochem | 2022 | 35649961 | PubTator, text mining | PubMed |
| Identification and application of a pair of noncompeting monoclonal antibodies broadly binding to the nucleocapsid proteins of SARS-CoV-2 variants including Omicron. | Virol J | 2022 | 35643510 | PubTator, text mining | PubMed |
| High-resolution analysis of long-term serum antibodies in humans following convalescence of SARS-CoV-2 infection. | Sci Rep | 2022 | 35641545 | PubTator, text mining | PubMed |
| Seeking antiviral drugs to inhibit SARS-CoV-2 RNA dependent RNA polymerase: A molecular docking analysis. | PLoS One | 2022 | 35639751 | PubTator, text mining | PubMed |
| All-viral tracing of monosynaptic inputs to single birthdate-defined neurons in the intact brain. | Cell Rep Methods | 2022 | 35637903 | PubTator, text mining | PubMed |
| An Overview of SARS-CoV-2 Molecular Diagnostics in Europe. | Clin Lab Med | 2022 | 35636820 | PubTator, text mining | PubMed |
| Analytic and Clinical Performance of Major Commercial Severe Acute Respiratory Syndrome Coronavirus 2 Molecular Assays in the United States. | Clin Lab Med | 2022 | 35636818 | PubTator, text mining | PubMed |
| Evidence of Infection with Zoonotic Mosquito-Borne Flaviviruses in Saltwater Crocodiles (Crocodylus porosus) in Northern Australia. | Viruses | 2022 | 35632847 | PubTator, text mining | PubMed |
| The Role of the Flavivirus Replicase in Viral Diversity and Adaptation. | Viruses | 2022 | 35632818 | PubTator, text mining | PubMed |
| SARS-CoV-2 Envelope (E) Protein Binds and Activates TLR2 Pathway: A Novel Molecular Target for COVID-19 Interventions. | Viruses | 2022 | 35632741 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64006/papers?page=52